BridgeBio Pharma, Inc. (BBIO)

67.90 -0.24 (-0.35%) USD  |  NASDAQ  |  Feb 23, 11:16
More

BridgeBio Pharma Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade